Skip to main content
. Author manuscript; available in PMC: 2013 Sep 11.
Published in final edited form as: J Immunol. 2009 Jun 15;182(12):7539–7547. doi: 10.4049/jimmunol.0804225

FIGURE 5.

FIGURE 5

Treatment of CD11c-DTR mice with DT causes depletion of GFP+ cells in lymph nodes but does not affect normal lymph node architecture 18 h after treatment. CD11c+ cells are revealed by GFP expression in CD11-DTR mice treated with PBS (A). The level of GFP detected was greatly reduced in mice treated with DT (B). Sections stained with CD19-specific (red) and CD3-specific (blue) Abs revealed no difference in normal lymph node architecture in T and B lymphocyte zones between PBS control mice (C) and DT-treated mice (D). The data in this experiment were obtained from four mice per group.